Centerra Gold CGAU

At a glance

One-line thesis. Centerra is a genuinely cheap, net-cash (~$498M) two-mine gold-copper producer riding a gold bull market — revenue +62% YoY in Q1 2026, ~8× forward earnings, buybacks that have retired a third of the share count since 2021 — but the entire earnings stream is gold-price beta from just two assets (Mount Milligan in B.C., Öksüt in Turkey), GAAP profits are heavily flattered by non-operating gains, momentum has already rolled over (−9.8% over 3 months while the market rallied), and there is no expert coverage in our KB to lean on — so this is a Watch, not a Buy, with a defined entry trigger near the 200-DMA.

1. What it is

Centerra Gold Inc. (NYSE: CGAU) is a Toronto-headquartered gold and copper producer engaged in the acquisition, exploration, development, and operation of gold, copper, and molybdenum deposits across North America, Turkey, and other international regions. Its two producing anchors are the Mount Milligan gold-copper mine (wholly owned, British Columbia, Canada) and the Öksüt Gold Mine (Turkey). Established 2002; CEO Paul Botond Stilicho Tomory; ~1,150 employees; listed on the NYSE since 2008 (per the FMP profile).

Revenue mix — a data caveat up front: the segment data in our feed is stale (latest fiscal 2022). At that snapshot the split was Gold $349M · Molybdenum $263M · Copper $243M · other by-products $16M, and by geography Canada $472M · United States $276M · Turkey $102M. Current-year segment splits are not in our data file, so we won't invent them — the honest read is simply: two producing mines (Canada + Turkey) plus a molybdenum business, with revenue overwhelmingly commodity-price-driven. FY2025 total revenue was $1.385B.

2. The expert thesis (traceable)

No expert-panel coverage — this note is fundamentals-driven. A search of the Synthos knowledge base returns zero traceable claims on CGAU: no bullish voices, no bearish voices, no management transcript ingested. That is the honest house standard for screen-surfaced names — CGAU entered the pipeline via the quant momentum screen (+122% 12-month return), not via conviction from any tracked thinker.

What this means for how to read the rest of this note:

• Conviction rating is Low by construction. Every claim in this dive reconciles to the FMP data file, not to expert judgment. There is no Jordi-Visser-grade voice underwriting the thesis, and no cautionary short thesis either.
• The bull and bear cases in §3 are built entirely from the fundamentals and the quant screen — treat them as a structured reading of the numbers, not as distilled expert insight.
• If tracked voices begin covering gold miners or CGAU specifically, this note gets re-scored with the KB evidence attached.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path; the cases bound the range.

Synthos fair value = the base case, ~$19 (+15%), anchored on the Street's $19 consensus and cross-checked by our own multiple math (8× 2027E EPS + net cash — assumptions labeled above). Two honesty flags: the "consensus" is effectively one live price target (high = low = median = $19), and every case above is a bet on the gold price wearing a valuation costume — the multiple is doing far less work here than the commodity assumption. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). CGAU is neither — it is a commodity cyclical, and we score it honestly as one:

• Forward growth: Street revenue path $1.385B (2025 actual) → $1.73B (2026E, +24.6%) → $1.88B (2027E, +8.7%) → $2.32B (2028E, +23.5%) → $3.45B (2029E, +48.6%) → $3.07B (2030E, −11.0%). EPS: $1.92 → $2.06 → $2.25 → $2.89 → $2.47.
• The 2nd derivative is noise, not signal. The growth rate whipsaws (+25%, +9%, +24%, +49%, −11%) — that is a project schedule plus a gold-price assumption, not accelerating demand. And the estimates themselves pencil the 2030 decline, the signature of a cyclical, not an exponential.
• Coverage is too thin to lean on: the out-year revenue estimates rest on 1 analyst (2028E–2030E), EPS on 6–8. We report them; we don't build conviction on them.
• Room to run exists but is bounded: a $3.3B market cap can certainly double in a gold bull market — but that is re-rating plus commodity beta, not compounding. There is no reinvestment flywheel: capex at 18% of revenue is sustaining-and-expansion spend to hold and grow ounces, not high-incremental-margin scaling.

Exponential Potential: Low (3/10). Own gold miners for cyclical torque and cheap optionality on the metal — never for compounding.

5. Financials (real numbers — FMP annual/quarterly)

• Revenue: FY2025 $1.385B, +14.0% (FY2024 $1.215B, +10.9%; FY2023 $1.095B; FY2022 $850M; FY2021 $900M). The gold bull market is landing directly in the top line.
• Quarterly trajectory: Q1 2025 $299.5M → Q2 $288.3M → Q3 $395.2M → Q4 $376.4M → Q1 2026 $484.7M (+61.8% YoY) — a genuine acceleration as realized gold prices climb.
• Margins: FY25 gross margin 33.5% (down from 39.7% FY24 on higher cash costs — TTM is 34.1%), but operating margin inflected to 22.7% FY25 (vs 6.3% FY24, which was crushed by $321M of D&A/impairment-heavy charges); TTM EBITDA margin 50.8%. Classic miner operating leverage — profitability inflates with the metal.
• Earnings quality — read carefully. FY25 GAAP net income $584.0M / EPS $2.90 was flattered by +$416.6M of non-operating income (income before tax $731M vs operating income $314M), concentrated in Q3–Q4 2025. The Street's adjusted FY25 EPS was ~$1.07–1.11 (adjusted quarterly actuals: $0.12, $0.25, $0.33, $0.41) — roughly a third of the GAAP figure. TTM income quality of 0.64 confirms cash income lags accounting income. Underwrite the adjusted numbers: Q1 2026 adjusted EPS $0.44 (beat the $0.41 estimate; GAAP was $0.40).
• Cash flow: FY25 operating CF $352.7M, capex −$258.1M (18.6% of revenue — heavy), FCF $94.6M. TTM FCF yield ~4.0%.
• Balance sheet — the fortress: cash + short-term investments $539.9M, plus $219M long-term investments, against total debt of just $29.6M (essentially all leases) → net cash ~$498M, about 15% of the market cap. Equity $2.06B, zero goodwill/intangibles — tangible book value per share $10.51, so the stock trades at 1.57× hard book.
• Share count — the quiet win: weighted shares out 296.6M (FY21) → 204.7M (FY25) → 199.6M (Q1 2026) — roughly a third of the company retired via buybacks ($95.3M repurchased in FY25 alone) while also paying a dividend.

6. Valuation — priced in or room?

The headline multiples scream cheap: ~5.2× trailing GAAP EPS, 3.6× EV/EBITDA, 1.8× EV/sales, 1.57× book, 4.0% FCF yield, 1.19% dividend yield (payout just 6.5%). FMP's letter rating is A (overall 4/5; DCF score 5/5) — the quant models love it. Two honest deflators: (1) the trailing P/E is on flattered GAAP earnings — on adjusted trailing EPS (~$1.43 TTM) it's ~11.5×, and on forward numbers 8.6× 2026E ($1.92) / 8.0× 2027E ($2.06) / 7.3× 2028E ($2.25) — still inexpensive for a net-cash producer, but ordinary for a mid-tier gold miner mid-cycle; (2) cheap multiples on peak-commodity earnings are the oldest value trap in mining — the E in that P/E is a gold-price bet. Street context: target $19 (+15%), but high = low = $19 — one live target, not a distribution; 3 Buy / 2 Hold. The honest summary: cheap on flattered trailing earnings, reasonable on forward — priced for gold staying roughly here, with the net cash and buyback as the margin of safety.

7. Technicals (from the tech block)

• Trend: intact but cooling. $16.51 sits below the 50-DMA ($16.98) — a short-term breakdown — but still above the rising 200-DMA ($15.60), and the 50 remains above the 200 (golden-cross posture holds).
• Location: −21.5% off the 52-week high ($21.03) — which is also the max drawdown from peak — and +142.8% off the 52-week low ($6.80). A big-run name in a real correction.
• Momentum: RSI(14) 53 — dead neutral. MACD −0.22 — negative, momentum pointing down.
• Relative strength (the tell): +122% 12-mo vs SPY +21.1% / QQQ +31.2% — enormous trailing outperformance. But the recent tape flipped: −9.8% over 3 months vs SPY +14.6% and QQQ +23.6% — this stopped being a leader a quarter ago. 6-mo +14.9% vs SPY +10.2% is roughly market-line.
• Read: technicals are deteriorating within an uptrend — exactly the profile that earns a Watch rather than a Buy. Price below the 50-DMA with negative MACD says don't chase; the rising 200-DMA near $15.60 is the logical test and our stated entry trigger. Lose the 200-DMA decisively and the momentum thesis that surfaced this name is dead.

8. Moat & competitive position

Gold miners don't have moats in the classic sense — gold is the ultimate undifferentiated product, and Centerra is a price taker. What substitutes for a moat is asset quality, jurisdiction, and balance sheet: Mount Milligan is a long-life gold-copper asset in Tier-1 British Columbia; Öksüt is low-cost but sits in Turkey (currency, permitting, and geopolitics have historically disrupted it); and the ~$498M net cash pile is a real competitive weapon in a downturn (counter-cyclical M&A, sustained buybacks). Concentration is the weakness: two producing mines means a single pit wall, permit, or leach-pad problem moves the whole company — this is not a diversified senior.

Peer set (FMP-supplied, market cap): Aris Mining $3.9B, Methanex $3.4B, Allied Gold $3.0B, Seabridge Gold $2.9B, Boise Cascade $2.6B, Perpetua Resources $2.6B, Fortuna Mining $2.6B, Endeavour Silver $2.5B, DRDGOLD $1.9B, Americas Gold and Silver $1.4B. A mixed list (Methanex and Boise Cascade are not miners) — the relevant read is that CGAU sits mid-pack among $1.5–4B junior/mid-tier precious-metals producers, where its net-cash balance sheet is a genuine differentiator. The most natural comps (mid-tier gold producers like Eldorado, IAMGOLD, SSR) are not in the supplied set — judge it against that cohort.

9. Management, capital allocation & guidance

• Capital allocation — the strongest part of the story: FY25 saw $95.3M of buybacks plus $41.8M of dividends (~$137M returned, versus $94.6M FCF — funded partly from the cash pile), on top of a multi-year program that has shrunk the share count ~33% since 2021. Buying back stock at 1.6× tangible book and ~8× forward earnings is rational, unlike much of the sector's habit of top-of-cycle M&A. The dividend (TTM $0.197/sh, 1.19% yield, 6.5% payout) is easily covered.
• Insider activity: the insider-trading feed in our data file is empty — no Form 4 data to read, so no signal either way; we say so rather than infer.
• Management guidance: no earnings-call transcript or guidance is ingested in our KB for CGAU (no _mgmt claims exist). The earnings calendar shows a consistent beat cadence on adjusted EPS: last four prints $0.25 vs $0.17e, $0.33 vs $0.22e, $0.41 vs $0.34e, $0.44 vs $0.41e — four straight beats, which at minimum says estimates have been trailing the gold price rather than leading it.
• CEO: Paul Tomory (per profile). We have no traceable claims on his capital-allocation philosophy — the FY25 actions above are the evidence.

10. Catalysts & what to watch

• Next earnings: 2026-07-28 (Q2 2026; Street adjusted EPS est $0.47; the feed's revenue estimate of ~$335M looks stale against Q1's $484.7M actual — treat the EPS line as the live number). A fifth straight beat keeps the estimate-revision engine running.
• The gold price — the real catalyst. Every other line item is downstream of it. A sustained move in either direction re-prices this stock more than anything the company does.
• Öksüt / Turkey operations: any permitting, currency, or operational disruption at the Turkish mine is the concentrated single-asset risk to watch.
• Capital-returns cadence: continuation (or acceleration) of the buyback with ~$498M net cash is the shareholder-yield leg of the thesis.
• Project pipeline news behind the Street's 2028–2029 revenue step-up ($2.3B → $3.4B) — thinly covered, so any concrete development milestone moves the out-year numbers.

Thesis tripwires (what would change the call): a decisive close below the 200-DMA (~$15.60) — trigger to engage on our terms or walk away; a gold-price breakdown; an adjusted-EPS miss ending the beat streak; any operational halt at Öksüt or Mount Milligan; buyback suspension.

11. Key risks

• Gold price (the dominant risk): a two-mine producer is leveraged commodity beta. The bear case isn't hypothetical — adjusted EPS was ~$1.10 as recently as 2025; a 15–20% gold correction likely sends earnings back there and the stock toward ~$11.
• Asset concentration: two producing mines. One tailings, permitting, or pit-wall event at either asset is a company-level event.
• Turkey / jurisdiction: Öksüt carries currency, tax, and political risk that Tier-1-only producers don't. (Centerra's history — including losing its former Kyrgyz flagship — is the sector's cautionary tale on jurisdiction, though that predates our data window.)
• Earnings quality: FY25 GAAP EPS of $2.90 vs Street-adjusted ~$1.07 — the 5× headline P/E materially overstates the cheapness; income quality 0.64.
• Momentum reversal: this name entered our pipeline on a +122% 12-month screen, but the last quarter is −9.8% against a +14.6% market — the factor that surfaced it is already fading.
• Thin coverage / single price target: consensus is effectively one $19 target and 1–2 revenue analysts in the out-years — the "Street" anchor is soft, and the 2029E estimates could be one model, not a view.
• No expert underwriting: zero KB claims means no independent thinker has made the bull case — this note is only as good as the data file behind it.

12. Verdict, position sizing & monitoring

Watch. Centerra is a well-run balance sheet attached to a gold-price bet: ~$498M net cash, a third of the share count retired in four years, four straight adjusted-EPS beats, and an 8× forward multiple with a 4% FCF yield. If we wanted pure gold-cycle torque in the flagship, this is a credible vehicle. But three things keep it off the Buy list today: the price action has already rolled over (below the 50-DMA, negative MACD, −9.8% vs a +14.6% market over 3 months), the cheapness is partly an illusion of flattered GAAP earnings at elevated gold prices, and there is no expert conviction anywhere in our KB — a screen-surfaced commodity cyclical with Low conviction does not earn new capital at a stalled price.

• The trigger: a tested-and-held pullback toward the rising 200-DMA (~$15.60) with gold stable — that's ~19% below our $19 base-case fair value and a sensible tactical entry. Alternatively, a reclaim of the 50-DMA ($16.98) with MACD turning positive would justify paying up. A decisive break below the 200-DMA instead kills the setup.
• Sizing if triggered: tactical, ~1–2% max, in a gold/commodity sleeve — sized as a cyclical trade with a defined exit, never a core anchor. Not suitable as a compounding holding (Exponential 3/10 says why).
• Monitoring: re-underwrite on the §10 tripwires; formal re-score at the 2026-07-28 print. This verdict is logged as a tracked Synthos call as of 2026-07-06 at $16.51.
• Single biggest risk: the gold price — everything else in this note is downstream of it.

Provenance & disclosures

• Traceability: 0 KB claims, 0 voices — a grep of the Synthos knowledge base returns no CGAU coverage. Nothing in this note is attributed to any expert; conviction is Low by construction, and kb_net_conviction is null because there is nothing to aggregate. Fabricated conviction is structurally impossible (claim-ID reconciliation).
• Data as-of: fundamentals 2026-03-31 (Q1 2026, filed 2026-04-29) · estimates & prices 2026-07-06 · segment data stale (fiscal 2022) — current segment splits are not in the file and are not invented here. The insider-trading feed is empty. Forward figures are analyst consensus (FMP), labeled as estimates; out-year revenue rests on 1–2 analysts.
• Earnings-quality caveat: FY25 GAAP EPS ($2.90) is roughly 3× the Street-adjusted figure (~$1.07) due to large non-operating gains; all valuation work above uses adjusted/forward numbers where possible.
• Street-consensus caveat: the $19 "consensus" price target is a single live target (high = low = median = $19); the Q2 revenue estimate in the earnings calendar appears stale versus Q1 actuals — both flagged rather than smoothed over.
• Peer caveat: the FMP-supplied peer list mixes in non-miners (Methanex, Boise Cascade) and omits the most natural mid-tier gold comps; judge against that cohort.
• Fair-value assumptions (labeled): base = 8× 2027E adjusted EPS of $2.06 plus ~$2.50/sh net cash ≈ $19, coinciding with the Street target; bull = ~9× a 2028E beat (~$2.60) plus cash ≈ $26; bear = ~8× a reversion to ~$1.10 adjusted EPS with partial cash credit ≈ $11.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-06. Prior versions available via the deep-dive version dropdown ("based on the info at the time").